Dr. Zaninovic’s interests include clinical and experimental embryology as well as stem cell biology. His research is currently focused on the development of new embryo selection protocols using time-lapse microscopy of developing embryos and application of Artificial Intelligence in the field of Embryology and IVF. In addition to his clinical duties, Dr. Zaninovic has ongoing research projects in human embryonic stem cell (hESCs) derivation. As Manager and Principal Investigator of Weill Cornell’s hESC Derivation Laboratory, Dr. Zaninovic has derived 43 stem cell lines.
AI in IVF: Selection Of Optimal Embryo
AI is not meant to replace the doctors and embryologists but rather to be used as a tool to medical practitioners in augmenting correct diagnoses and increase the robustness of the treatments and increase pregnancy and LB rates.
Researchers have long been recognizing the uniqueness of women’s health and the substantial effect on clinical practice, acknowledging the increasing appreciation of the importance of multidisciplinary approaches to health and disease. In every organ system, there are diseases that are unique to women, more common in women than in men, or characterized by differences in disease course in women compared with men. This session will include the effect of women’s health on the following topics: